Pancreatic NETs frequently exhibit changes in genes such as MEN1, DAXX, ATRX, TSC1, TSC2, CDKN1A, and CDKN1B, along with alterations in CDKN2A and SETD2 in metastatic lesions. The gene discussed is CDKN1A; the disease is pancreatic neuroendocrine tumor.